Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS ®) Mouthpiece and Controller

Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) -- -- Proceeds from recent stock issuances through the Company’s At-The-Market (“ATM”) program extends cash runway into the third quarter 2024 --…#atm #newtown #helius #cms #healthcare #levelii #neuromodulation #ponstherapy #daneandreeff #ponsdevice
Source: Reuters: Health - Category: Consumer Health News Source Type: news